These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37129766)
1. Superresolution live-cell imaging reveals that the localization of TMEM106B to filopodia in oligodendrocytes is compromised by the hypomyelination-related D252N mutation. Xing S; Zheng X; Yan H; Mo Y; Duan R; Chen Z; Wang K; Gao K; Chen T; Zhao S; Wang J; Chen L Sci China Life Sci; 2023 Aug; 66(8):1858-1868. PubMed ID: 37129766 [TBL] [Abstract][Full Text] [Related]
2. A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination. Feng T; Sheng RR; Solé-Domènech S; Ullah M; Zhou X; Mendoza CS; Enriquez LCM; Katz II; Paushter DH; Sullivan PM; Wu X; Maxfield FR; Hu F Brain; 2020 Jul; 143(7):2255-2271. PubMed ID: 32572497 [TBL] [Abstract][Full Text] [Related]
3. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies. Zhou X; Nicholson AM; Ren Y; Brooks M; Jiang P; Zuberi A; Phuoc HN; Perkerson RB; Matchett B; Parsons TM; Finch NA; Lin W; Qiao W; Castanedes-Casey M; Phillips V; Librero AL; Asmann Y; Bu G; Murray ME; Lutz C; Dickson DW; Rademakers R Brain; 2020 Jun; 143(6):1905-1919. PubMed ID: 32504082 [TBL] [Abstract][Full Text] [Related]
4. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy. Simons C; Dyment D; Bent SJ; Crawford J; D'Hooghe M; Kohlschütter A; Venkateswaran S; Helman G; Poll-The BT; Makowski CC; Ito Y; Kernohan K; Hartley T; Waisfisz Q; Taft RJ; ; van der Knaap MS; Wolf NI Brain; 2017 Dec; 140(12):3105-3111. PubMed ID: 29186371 [TBL] [Abstract][Full Text] [Related]
5. Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B. Stagi M; Klein ZA; Gould TJ; Bewersdorf J; Strittmatter SM Mol Cell Neurosci; 2014 Jul; 61():226-40. PubMed ID: 25066864 [TBL] [Abstract][Full Text] [Related]
6. A recurrent TMEM106B mutation in hypomyelinating leukodystrophy: A rapid diagnostic assay. Ikemoto S; Hamano SI; Kikuchi K; Koichihara R; Hirata Y; Matsuura R; Hiraide T; Nakashima M; Inoue K; Kurosawa K; Saitsu H Brain Dev; 2020 Sep; 42(8):603-606. PubMed ID: 32595021 [TBL] [Abstract][Full Text] [Related]
8. Identification of a de novo Mutation in TMEM106B in a Saudi Child Causes Hypomyelination Leukodystrophy. Alotaibi L; Alqasmi A Glob Med Genet; 2023 Jan; 10(1):38-41. PubMed ID: 36950148 [TBL] [Abstract][Full Text] [Related]
9. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease. Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418 [TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis. Fletcher JL; Kondagari GS; Vite CH; Williamson P; Taylor RM J Neuropathol Exp Neurol; 2014 Jun; 73(6):536-47. PubMed ID: 24806306 [TBL] [Abstract][Full Text] [Related]
11. Atp-binding cassette transporter ABC2/ABCA2 in the rat brain: a novel mammalian lysosome-associated membrane protein and a specific marker for oligodendrocytes but not for myelin sheaths. Zhou C; Zhao L; Inagaki N; Guan J; Nakajo S; Hirabayashi T; Kikuyama S; Shioda S J Neurosci; 2001 Feb; 21(3):849-57. PubMed ID: 11157071 [TBL] [Abstract][Full Text] [Related]
12. Ulk4 deficiency leads to hypomyelination in mice. Liu M; Xu P; Guan Z; Qian X; Dockery P; Fitzgerald U; O'Brien T; Shen S Glia; 2018 Jan; 66(1):175-190. PubMed ID: 29034508 [TBL] [Abstract][Full Text] [Related]
13. The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes. Schwenk BM; Lang CM; Hogl S; Tahirovic S; Orozco D; Rentzsch K; Lichtenthaler SF; Hoogenraad CC; Capell A; Haass C; Edbauer D EMBO J; 2014 Mar; 33(5):450-67. PubMed ID: 24357581 [TBL] [Abstract][Full Text] [Related]
14. Physiological and pathological functions of TMEM106B in neurodegenerative diseases. Zhu M; Zhang G; Meng L; Xiao T; Fang X; Zhang Z Cell Mol Life Sci; 2024 May; 81(1):209. PubMed ID: 38710967 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Expression of Vacuolar Protein Sorting 11 (Vps11) in Mammalian Oligodendrocytes. Skoff RP; Bessert D; Banerjee S; Luo X; Thummel R ASN Neuro; 2021; 13():17590914211009851. PubMed ID: 33874780 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish. Yin W; Hu B Exp Neurol; 2014 Jan; 251():72-83. PubMed ID: 24262204 [TBL] [Abstract][Full Text] [Related]
17. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528 [TBL] [Abstract][Full Text] [Related]
18. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency. Zhou X; Sun L; Brady OA; Murphy KA; Hu F Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008 [TBL] [Abstract][Full Text] [Related]
19. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Brady OA; Zheng Y; Murphy K; Huang M; Hu F Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129 [TBL] [Abstract][Full Text] [Related]